Ticker League

Abbott Laboratories (ABT) Free Cash Flow Bridge

Pinpoint what moved Abbott Laboratories's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

+10.83%

OCF YoY

+5.74%

Capex YoY

-9.03%

FCF Conversion Δ

+3.6 pp

Free cash flow bridge for Abbott Laboratories (ABT) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $721.00M

FCF bridge breakdown for Abbott Laboratories (ABT) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$6.66B
  • Operating Cash Flow$514.00M
  • Capital Expenditure$207.00M
  • Free Cash Flow$7.38B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology